BATS | ETF
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole.
The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
VERV | Verve Therapeutics Inc | Healthcare | Biotechnology | 5.08% |
NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.04% |
DNA | Ginkgo Bioworks Holdings | Healthcare | Biotechnology | 2.98% |
CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.86% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.53% |
NSIS-B | Novonesis (Novozymes) A/S | Basic Materials | Specialty Chemicals | 2.31% |
ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.28% |
SANA | Sana Biotechnology Inc | Healthcare | Biotechnology | 2.24% |
TXG | 10X Genomics Inc | Healthcare | Health Information Services | 2.20% |
AGIO | Agios Pharm | Healthcare | Biotechnology | 2.18% |
RGNX | Regenxbio Inc | Healthcare | Biotechnology | 2.00% |
EDIT | Editas Medicine Inc | Healthcare | Biotechnology | 1.98% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 1.98% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.93% |
STOK | Stoke Therapeutics Inc | Healthcare | Biotechnology | 1.93% |
VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 1.86% |
TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 1.70% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 1.70% |
BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 1.69% |
NOVN | Novartis AG | Healthcare | Drug Manufacturers - General | 1.68% |